Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The Inhaled Corticosteroid (ICS) Device market is seeing a significant surge in popularity, basically determined by the rising pervasiveness of respiratory circumstances like asthma and chronic obstructive pulmonary disease (COPD). Inhaled corticosteroids are a foundation of dealing with these respiratory diseases, contributing essentially to the extension of the market.
The market is encountering a remarkable pattern towards mix treatments, where inhaled corticosteroids are in many cases recommended related to long-acting bronchodilators. This approach gives far reaching management of respiratory circumstances and is gaining reputation among healthcare suppliers, adding to the general growth of the ICS device market.
Pediatric respiratory circumstances, including asthma, are on the ascent, prompting an expanded spotlight on pediatric respiratory care. Inhaled corticosteroid devices tailored for kids are gaining unmistakable quality, tending to the necessities of pediatric patients and their caregivers. This pediatric center is a critical driver of market growth.
The combination of computerized health arrangements in respiratory care is impacting the ICS device market. Brilliant inhalers and computerized stages that help patients in medicine adherence, screen use designs, and give constant information to healthcare suppliers are gaining footing. This shift towards advanced health arrangements upgrades patient commitment and adds to better disease management.
The market is encountering the effect of conventional rivalry, prompting evaluating pressures on marked inhaled corticosteroid devices. As patent terminations happen, non-exclusive choices enter the market, testing established brands. This pattern adds to cost-cognizant healthcare practices and impacts buying choices by healthcare suppliers and payers.
Producers in the ICS device market is progressively tending to natural sustainability concerns. Endeavors are being made to foster inward breath devices with decreased natural effect, including eco-accommodating materials and charges. This naturally cognizant methodology lines up with more extensive worldwide drives and mirrors a developing awareness of the healthcare business' environmental impression.
Inhaled Corticosteroid Device Market Highlights:
Inhaler Corticosteroid Device Market Overview
Inhaled Corticosteroid Device Market Size was valued at USD 0.48 Billion in 2023. The Inhaled Corticosteroid Device industry is projected to grow from USD 0.56 Billion in 2024 to USD 0.98 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.11% during the forecast period (2024 - 2032).
Asthma is a disease of the entire respiratory tract, including large, intermediate and small airways. Asthma led to inflammation and obstruction of respiratory tract. Patients have various treatment options for asthma, particularly for young and elderly patients. Hence this has led to significant interest on the part of the inhaler device which is easy to use.
Inhaled corticosteroid is the most commonly used tool for the treatment of asthma. As with increasing pollution and increasing incidences of asthma, many companies are engaged in the development of new inhaler corticosteroid devices. Hence this factor is responsible for the growth of the inhaled corticosteroid device market.
However, the high cost of treatment, misuse of funding and lack of awareness are some of the factors which are hampering the growth of the market during the forecast period.
Inhaled Corticosteroid Device Market Segmentation
The inhaler corticosteroid device market is segmented into types of steroid inhalers, applications, and end-users.
Based on types of steroid inhaler the market is segmented into beclomethasone dipropionate, budesonide, fluticasone inhaler powder, mometasone.
On the basis of application, inhaler corticosteroid device market is segmented into asthma and COPD (chronic obstructive pulmonary disease), and other respiratory diseases.
Based on end-user the market is segmented into hospitals, clinics, and respiratory care centers.
Inhaled Corticosteroid Device Market Key Players
Some of the key players in the inhaler corticosteroid device market are:
- Plumage Therapeutics LLP
- Pearl Therapeutic Inc
- Teijin LTD
- Glaxo’s Advair
- LIYEN, Inc
- Amgen Inc
- Kos Pharmaceutical, Inc
- Teva Pharmaceutical
Inhaled Corticosteroid Device Market Regional Analysis
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The inhaler corticosteroid device market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European inhaler corticosteroid device market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The inhaler corticosteroid device market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The inhaler corticosteroid device market in the Middle East and Africa has been segmented into the Middle East and Africa.
In terms of market value, North America will dominate the inhaler corticosteroid device market during the forecast period. Increasing incidences of life-threatening illness such as chronic obstructive pulmonary disease, asthma and many more are some of the factors which are responsible for the growth of the market during the forecast period. The European market is expected to be the second-largest inhaler corticosteroid device market.
The market growth in this region can be attributed to government funding and support of the healthcare sector coupled with increasing research and development. Moreover, a growing patient for asthma worldwide, increasing number of qualified physicians for inhaler corticosteroid device center and expanding aging demographics are some of the factors responsible for the rise in inhaler corticosteroid device market.
Asia-Pacific is expected to be the fastest-growing market during the forecast period owing to the increasing prevalence of asthma, rising investments in healthcare, increasing geriatric population, and expansions by market players in the region. Asia-Pacific is giving the strong competition in the inhaler corticosteroid device market by producing a cost-effective treatment that is high in demand in local as well as in the global market.
The market in the Middle East and Africa is expected to account for the smallest share in the inhaler corticosteroid device market due to the underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.
Market of Inhaler Corticosteroid Device, by Steroid Inhaler Types
- Beclomethasone Dipropionate
- Budesonide
- Fluticasone Inhaler Powder
- Mometasone
Market of Inhaler Corticosteroid Device, by Application
- Asthma
- COPD (Chronic Obstructive Pulmonary Disease)
- Others
Market of Inhaler Corticosteroid Device, by End-User
- Hospitals and Clinics
- Academic and Research Institutes
- Respiratory Care Center
Market of Inhaler Corticosteroid Device, by Region
Americas
- North America
- US
- Canada
- South America
Europe
- Western Europe
- Germany
- France
- Italy
- Spain
- UK
- Rest of Western Europe
- Eastern Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Middle East & Africa
- Middle East
- Africa
Intended Audience
- Hospitals and clinics
- Laboratories and associations
- Healthcare providers
- Medical device manufacturers
- Research institutes and academic centers
- Government associations
- Market research and consulting
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
